Pasteurella (e.g., Pasteurella multocida, Pasteurella hemolytica, etc.)
Subclass of:
424 - Drug, bio-affecting and body treating compositions
424184100 - ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.)
424234100 - Bacterium or component thereof or substance produced by said bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, etc.)
Patent class list (only not empty are listed)
Deeper subclasses:
Class / Patent application number | Description | Number of patent applications / Date published |
---|---|---|
424255100 | Pasteurella (e.g., Pasteurella multocida, Pasteurella hemolytica, etc.) | 9 |
20080241192 | Vaccination against multiple serotypes of pasteurella multocida - The present invention provides methods for inducing cross-protective immunity against virulent strains of | 10-02-2008 |
20090202594 | Anti-bacterial Vaccine Compositions - Gram negative bacterial virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel gram negative bacterial mutants useful in vaccines. | 08-13-2009 |
20090246229 | Subunit vaccine of pasteurella multocida in veterinary uses - The present invention declaims the use of | 10-01-2009 |
20090252766 | ATTENUATED GRAM NEGATIVE BACTERIA - Disclosed and claimed are a mutant of a gram negative bacterium, wherein said bacterium has at least one mutation in a nucleotide sequence which codes for a polypeptide having an identity which is equal or more than 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% with an amino acid sequence coded by a nucleotide sequence selected from the group consisting of nucleotide sequences identified SEQ ID NO: 2, 6, 9, 12, 16, 19, 22, 25, 28, 31, 34, 37, 40, 43, 46, 49, 52, 55, 58, 61, 64, 67, 70, 75, 78, 81, 84, 87, 90, 93; said mutation resulting in attenuated virulence of the bacterium. Immunogenic compositions and vaccines containing such a mutant are also disclosed and claimed. | 10-08-2009 |
20100322975 | Anti-bacterial Vaccine Compositions - Gram negative bacterial virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel gram negative bacterial mutants useful in vaccines. | 12-23-2010 |
20110212132 | PATHOGEN FOR BACTERIAL POULTRY DISEASE - The invention belongs to the field of animal health and in particular the causative agent of a new bacterial poultry disease, | 09-01-2011 |
20120148625 | Anti-bacterial Vaccine Compositions - Gram negative bacterial virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel gram negative bacterial mutants useful in vaccines. | 06-14-2012 |
20140023684 | Vaccine Against Pasteurellaceae - The invention relates to vaccines providing protection against infections caused by members of the Pasteurellaceae family comprising outer membrane vesicles as the only active components, wherein the outer membrane vesicles are obtained from one or more strains of the Pasteurellaceae family, with the proviso that hypervesiculating strains are excluded. The invention also relates to a method for preparing such a vaccine. | 01-23-2014 |
20140170190 | Attenuated Mannheimia haemolytica Vaccines and Methods of Making and Use - The present invention provides attenuated | 06-19-2014 |